Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening

Abstract Patients with well-differentiated thyroid cancer, especially papillary thyroid cancer (PTC), are treated with surgical resection of the thyroid gland. This is followed by post-operative radioactive iodine (I 131 ), resulting in total thyroid ablation. Unfortunately, about 15-33% of PTC patients are unable to take up I 131 , […]

View Original Source at Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening